| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 564.21B | 561.17B | 547.06B | 525.60B | 503.35B | 583.55B |
| Gross Profit | 135.81B | 135.05B | 131.96B | 118.30B | 122.28B | 190.07B |
| EBITDA | 40.66B | 41.40B | 113.46B | 45.85B | 70.30B | 47.09B |
| Net Income | 7.06B | 5.46B | 61.31B | 16.88B | 33.78B | 18.74B |
Balance Sheet | ||||||
| Total Assets | 547.97B | 520.42B | 566.00B | 487.44B | 458.79B | 453.65B |
| Cash, Cash Equivalents and Short-Term Investments | 43.57B | 28.56B | 64.53B | 21.10B | 23.61B | 19.26B |
| Total Debt | 123.92B | 104.73B | 86.82B | 101.33B | 89.26B | 104.01B |
| Total Liabilities | 279.73B | 249.32B | 283.86B | 259.19B | 250.76B | 251.14B |
| Stockholders Equity | 263.57B | 266.33B | 277.18B | 223.03B | 206.07B | 199.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -44.68B | 23.44B | -205.00M | 21.39B | 10.36B |
| Operating Cash Flow | 0.00 | -12.46B | 56.58B | 19.38B | 40.27B | 38.54B |
| Investing Cash Flow | 0.00 | -18.79B | 25.22B | -25.46B | 8.37B | -25.30B |
| Financing Cash Flow | 0.00 | -5.03B | -38.62B | 2.92B | -44.52B | -2.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥539.34B | 28.74 | 9.28% | 1.30% | 5.50% | 27.32% | |
68 Neutral | ¥200.39B | 4.56 | ― | 2.47% | 0.32% | -20.60% | |
65 Neutral | ¥381.25B | 68.53 | 1.86% | 1.64% | 8.40% | -23.50% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.07T | 13.62 | 5.97% | 2.96% | 2.79% | -6.46% | |
59 Neutral | ¥427.56B | 10.37 | ― | 2.42% | 2.33% | -8.76% | |
57 Neutral | ¥311.78B | 10.01 | ― | 1.45% | 20.02% | ― |